1346597-47-4 Usage
Uses
Used in Pharmaceutical Research:
Ethyl 3-[Benzyl(Methyl)aMino]-2,2-difluoropropanoate is employed as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with distinct mechanisms of action, potentially leading to more effective treatments for a range of medical conditions.
Used in Organic Synthesis:
In the field of organic synthesis, Ethyl 3-[Benzyl(Methyl)aMino]-2,2-difluoropropanoate serves as a versatile building block for the creation of complex organic molecules. Its reactivity and functional groups enable chemists to construct a wide array of compounds with diverse applications in various industries.
Used in Drug Development:
Ethyl 3-[Benzyl(Methyl)aMino]-2,2-difluoropropanoate is utilized as a precursor in the development of new drugs. Its incorporation into drug molecules can impart specific medicinal properties, such as enhanced potency, selectivity, or bioavailability. Ethyl 3-[Benzyl(Methyl)aMino]-2,2-difluoropropanoate plays a crucial role in advancing the discovery and design of innovative therapeutic agents.
Used in Chemical Research:
In the context of chemical research, Ethyl 3-[Benzyl(Methyl)aMino]-2,2-difluoropropanoate is employed as a model compound to study various chemical reactions and mechanisms. Its unique structure provides insights into the reactivity and behavior of similar compounds, contributing to a deeper understanding of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1346597-47-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,6,5,9 and 7 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1346597-47:
(9*1)+(8*3)+(7*4)+(6*6)+(5*5)+(4*9)+(3*7)+(2*4)+(1*7)=194
194 % 10 = 4
So 1346597-47-4 is a valid CAS Registry Number.
1346597-47-4Relevant academic research and scientific papers
TRICYCLIC COMPOUNDS FOR USE AS KINASE INHIBITORS
-
Page/Page column 68, (2013/03/26)
There is provided compounds of formula (I), wherein R1, R2, X, R3 and R4 have meanings given in the description (and which compounds are optionally substituted as indicated in the description), and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PIM family kinase, such as PIM-1, PIM-2 and/or PIM-3) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease. There is also provided combinations comprising the compounds of formula (I).
